About 98,000 results
Open links in new tab
Bristol Myers Beats $6.4 Billion Lawsuit Over Delayed Cancer Drug
Bristol Myers beats $6.4 billion lawsuit over delayed cancer drug
Federal Judge Dismisses $6.4B Lawsuit Against BMS Over Celgene ...
Bristol-Myers Gets $6.4 Billion Suit Over Celgene CVRs Tossed
BMS/Celgene merger payout evaporates as CVR deadline passes
Celgene News: CELG Stock Jumps on Sale of Otezla to Amgen - Yahoo Finance
Celgene News: Why CELG Stock Is Surging Today - Yahoo Finance
Bristol-Myers completes $95B acquisition of Celgene after …
Bristol-Myers Squibb Completes Acquisition of Celgene, …
Bristol-Myers Squibb to Acquire Celgene for About $74 Billion